To use multimodal assessment (fluorescein angiography [FA], color fundus photography [CFP], and/or spectral domain OCT [SD-OCT]) to reevaluate macular atrophy (MA) and macular neovascularization (MNV) type in the HARBOR trial according to the Consensus on Neovascular AMD Nomenclature criteria; and to determine if there are any associations between baseline demographic factors, ocular characteristics, and/or treatment for neovascular age-related macular degeneration (nAMD) and the development of MA by month 24.

Characteristics That Correlate with Macular Atrophy in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration / G. Staurenghi, M. Cozzi, S. Sadda, L. Hill, S. Gune. - In: OPHTHALMOLOGY RETINA. - ISSN 2468-6530. - 7:4(2023 Apr), pp. 300-306. [10.1016/j.oret.2022.11.002]

Characteristics That Correlate with Macular Atrophy in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration

G. Staurenghi
Primo
;
M. Cozzi
Secondo
;
2023

Abstract

To use multimodal assessment (fluorescein angiography [FA], color fundus photography [CFP], and/or spectral domain OCT [SD-OCT]) to reevaluate macular atrophy (MA) and macular neovascularization (MNV) type in the HARBOR trial according to the Consensus on Neovascular AMD Nomenclature criteria; and to determine if there are any associations between baseline demographic factors, ocular characteristics, and/or treatment for neovascular age-related macular degeneration (nAMD) and the development of MA by month 24.
Intraretinal fluid; Neovascular age-related macular degeneration (nAMD); Ranibizumab; Subretinal fluid
Settore MED/30 - Malattie Apparato Visivo
Settore MED/50 - Scienze Tecniche Mediche Applicate
Settore MEDS-17/A - Malattie dell'apparato visivo
Settore MEDS-26/C - Scienze delle professioni sanitarie della riabilitazione
apr-2023
11-nov-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
2023.04 Characteristics that Correlate with Macular Atrophy in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration.pdf

accesso riservato

Descrizione: Original Article
Tipologia: Publisher's version/PDF
Dimensione 387.65 kB
Formato Adobe PDF
387.65 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/945731
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact